Furthermore, aberrant activation of the PI3K/Akt/mTOR signaling pathway in T-ALL commonly results from loss-of-function mutations or deletions of the tumor suppressor gene PTEN, detected in approximately 10% of cases. This evidence concerns the gene AKT1 and acute lymphoblastic leukemia.